维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Bob G.Schultz"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	The role of statins in both cognitive impairment and protection against dementia:a tale of two mechanisms显示文摘Nearly 30% of adults 40 years and older in the United States are on a statin.Their widespread use heightens the importance of careful consideration of their varied effects on the body.Although randomized controlled trials have not confirmed cognitive impairing effects with statins,continuing evidence suggests statins have the ability to cause reversible cognitive impairment in some patients.Paradoxically,statins have also been shown to decrease the risk of dementia,Alzheimer’s disease,and improve cognitive impairment in some cases.However,randomized controlled trials have similarly failed to find the beneficial effect.Supporting evidence for both claims is compelling whereas known limitations of the clinical trials may explain the lack of findings.This narrative review aims to explain why there is still controversy and how both effects can,and may,be possible.The mechanisms that have been hypothesized for each effect are seemingly independent from one another and may explain the contradicting results.Being mindful of the complex effects of statins,health care providers need to be able to identify patients who are at risk for or already experiencing cognitive impairment from statin use while also identifying those who could potentially decrease their risk of dementia with statins.	Bob G.Schultz Denise K.Patten Daniel J.Berlau	2018	Translational Neurodegeneration2018，7，1：	6

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费